Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of Natural Killer Cells in Severe Asthma Patients in Comparison With Control Subjects: Identification of Biomarkers, Response During Virus-induced Exacerbations, and Interaction With Bronchial Epithelial Cells

NCT06015256 is registered in ClinicalTrials.gov with Institut National de la Santé Et de la Recherche Médicale, France as lead sponsor.

NCT NCT06015256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06015256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of Natural Killer Cells in Severe Asthma Patients in Comparison With Control Subjects: Identification of Biomarkers, Response During Virus-induced Exacerbations, and Interaction With Bronchial Epithelial Cells
Lead sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Phase
Not applicable
Overall status
Recruiting
Start date
September 7, 2023
Completion date
September 30, 2030
Enrollment
448 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma acute